ADVENTRX Pharmaceuticals (ANX)
|
0.74
-0.013 (-1.73%)
|
|
|
|
ANX additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ANX Profile
•
Exchange
AMEX
•
Held by these Mutual Funds
•
Competitors
•
Executives
Mr. Brian M. Culley M.A. B.A.
40
Chief Exec. Officer and Director
Mr. Patrick L. Keran J.D.
Pres
Chief Operating officer Principal Financial Officer and Sec.
Mr. Gregory D. Gorgas
Sr. VP of Commercial
Mr. Mark E. Erwin
Sr. VP of Operations
Ms. Brandi L. Roberts CPA B.A.
38
Principal Accounting Officer and VP of Fin.
40
Chief Exec. Officer and Director
Mr. Patrick L. Keran J.D.
Pres
Chief Operating officer Principal Financial Officer and Sec.
Mr. Gregory D. Gorgas
Sr. VP of Commercial
Mr. Mark E. Erwin
Sr. VP of Operations
Ms. Brandi L. Roberts CPA B.A.
38
Principal Accounting Officer and VP of Fin.
•
Index Membership
N/A
•
Employee Count
1
Special Offers
Competitors
ANX earnings
Date
Actual
Expected
Prev Yr Qtr
3/7/2012
-0.06
-0.09
-0.15
11/7/2011
-0.13
-0.13
-0.13
8/8/2011
-0.17
-0.13
-0.39
